[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

October 2019 - July 1959

Decade

Year

Issue

August 2015, Vol 72, No. 8, Pages 741-851

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):741. doi:10.1001/jamapsychiatry.2014.1900
Editorial

Resting-State Functional Connectivity in Psychiatric Disorders

Abstract Full Text
JAMA Psychiatry. 2015;72(8):743-744. doi:10.1001/jamapsychiatry.2015.0484

Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2015;72(8):745-746. doi:10.1001/jamapsychiatry.2015.0485
Original Investigation

Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):747-756. doi:10.1001/jamapsychiatry.2015.0533

This study of brain tissue suggests that lower expression of NARP may lower the excitatory drive in schizophrenia.

Epidemiology of DSM-5 Alcohol Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions III

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):757-766. doi:10.1001/jamapsychiatry.2015.0584

This national epidemiologic survey finds that alcohol use disorder is highly prevalent, highly comorbid, and disabling, with an urgent need for education of the public and policy makers, destigmatization of the disorder, and encouragement of those with the disorder to seek treatment.

Increased Functional Connectivity Between Subcortical and Cortical Resting-State Networks in Autism Spectrum Disorder

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):767-777. doi:10.1001/jamapsychiatry.2015.0101

This resting-state functional magnetic resonance imaging study compares the intrinsic functional connectivity between brain networks in a large sample of individuals with autism spectrum disorder and typically developing control subjects.

Neurobiology of Sensory Overresponsivity in Youth With Autism Spectrum Disorders

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):778-786. doi:10.1001/jamapsychiatry.2015.0737

This fMRI study determines differences in brain responses, habituation, and connectivity during exposure to mildly aversive sensory stimuli in youth with autism spectrum disorders (ASDs) and sensory overresponsivity (SOR) compared with youth with ASDs without SOR and control subjects.

Familial Risks of Tourette Syndrome and Chronic Tic Disorders: A Population-Based Cohort Study

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):787-793. doi:10.1001/jamapsychiatry.2015.0627

This population cohort, multigenerational, family study found that chronic tic disorders, including Tourette syndrome, cluster in families because of genetic disorders.

Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):794-802. doi:10.1001/jamapsychiatry.2015.0125

This cross-sectional positron emission tomography study describes an overactive presynaptic serotonin system, with increased serotonin synthesis and transporter availability, in patients with social anxiety disorder.

Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):803-812. doi:10.1001/jamapsychiatry.2015.0712

This case-control study investigates the association between IQ and brain measures in patients with schizophrenia across time.

Spontaneous Gamma Activity in Schizophrenia

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):813-821. doi:10.1001/jamapsychiatry.2014.2642

This cross-sectional study reports an increase in spontaneous gamma activity during auditory steady-state stimulation in schizophrenia, reflecting a disruption in the normal balance of excitation and inhibition.

Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia : A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):822-829. doi:10.1001/jamapsychiatry.2015.0270

This randomized clinical trial shows that long-acting injectable risperidone resulted in better clinical outcomes than oral risperidone.

Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):830-839. doi:10.1001/jamapsychiatry.2015.0241

This placebo-controlled randomized clinical trial evaluates the safety and efficacy of the 3-month formulation of paliperidone palmitate in delaying time to relapse of schizophrenia symptoms.

Special Communication

Neural Oscillations and Synchrony in Brain Dysfunction and Neuropsychiatric Disorders: It’s About Time

Abstract Full Text
JAMA Psychiatry. 2015;72(8):840-844. doi:10.1001/jamapsychiatry.2015.0483

This Special Communication reviews some of the major methods and measures used to characterize neural oscillations in an effort to improve understanding of the temporal organization of neuronal network activity.

Neuroscience and Psychiatry

Serotonin States and Social Anxiety

Abstract Full Text
JAMA Psychiatry. 2015;72(8):845-847. doi:10.1001/jamapsychiatry.2015.0486

This Neuroscience and Psychiatry article discusses the role in social anxiety of a novel disrupted regulatory sequence in serotonin neurochemistry resulting from overactive serotonin signaling.

Comment & Response

Addressing Depression and Suicide Among Physician Trainees—Reply

Abstract Full Text
JAMA Psychiatry. 2015;72(8):848-849. doi:10.1001/jamapsychiatry.2015.0639

Addressing Depression and Suicide Among Physician Trainees

Abstract Full Text
JAMA Psychiatry. 2015;72(8):848. doi:10.1001/jamapsychiatry.2015.0643

Abuse-Deterrent Formulations of Prescription Opioids

Abstract Full Text
JAMA Psychiatry. 2015;72(8):849-850. doi:10.1001/jamapsychiatry.2015.0721

Abuse-Deterrent Formulations of Prescription Opioids

Abstract Full Text
JAMA Psychiatry. 2015;72(8):849. doi:10.1001/jamapsychiatry.2015.0723

Abuse Deterrent Formulations of Prescription Opioids—Reply

Abstract Full Text
JAMA Psychiatry. 2015;72(8):850-851. doi:10.1001/jamapsychiatry.2015.0674
Correction

Incorrect Information in Abstract and Table

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):851. doi:10.1001/jamapsychiatry.2014.2900

Information Omitted From Analyses

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):851. doi:10.1001/jamapsychiatry.2014.2929
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2015;72(8):742. doi:10.1001/jamapsychiatry.2014.1901
×